Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Spinal Diseases × Melphalan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 233 Lymphoma 121 Leukemia, Myeloid, Acute 92 Lymphoma, Non-Hodgkin 91 Neoplasms, Plasma Cell 85 Precursor Cell Lymphoblastic Leukemia-Lymphoma 83 Myelodysplastic Syndromes 83 Leukemia 75 Hodgkin Disease 73 Leukemia, Lymphocytic, Chronic, B-Cell 60 Lymphoma, Large B-Cell, Diffuse 54 Lymphoma, Mantle-Cell 49 Lymphoma, Follicular 48 Burkitt Lymphoma 40 Neuroblastoma 38 Lymphoma, Large-Cell, Immunoblastic 36 Recurrence 32 Lymphoma, B-Cell, Marginal Zone 32 Myeloproliferative Disorders 29 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 28 Hematologic Neoplasms 28 Immunoglobulin Light-chain Amyloidosis 27 Leukemia, Myeloid, Accelerated Phase 24 Leukemia, Myelomonocytic, Chronic 23 Leukemia, Myeloid, Chronic-Phase 23 Congenital Abnormalities 21 Primary Myelofibrosis 19 Melanoma 19 Graft vs Host Disease 18 Dendritic Cell Sarcoma, Interdigitating 18

Interventions

Radiotherapy 1 Patient Discharge 1 Melphalan 1 Magnetic Resonance Imaging 1 Infusions, Intra-Arterial 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01637766 2020-08-03

SIAC

Weill Medical College of Cornell University

Phase 1 Completed

Spinal Cord Compression, Spinal Cord Neoplasms, Spinal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡